Nasdaq · CIK 0000907242
MCRI MONARCH CASINO & RESORT INC
Insider trading from SEC Form 4. Last filing 22 d ago. Close $114.34 on Oct 9, 2026, +30% from the 52-week low and -14% from the high.
In brief
MONARCH CASINO & RESORT INC (MCRI) has 27 SEC Form 4 filings on file from 7 insiders, the latest filed on Sep 21, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $620k, net -$620k.
7 open-market trades have been scored at MCRI. The newest: John Farahi (CEO) sold $620k of stock on Sep 17, 2026, filed Sep 21, 2026, scored 45 (moderate). The largest of the 7 shown: Craig F Sullivan (director) sold $1.3M on Jul 22, 2025, scored 68 (notable). 2 insiders sold within 14 days of each other around Jul 22, 2025.
21 Form 144 notices of planned sales are on file, the latest filed Sep 16, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MONARCH CASINO & RESORT INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | John Farahi CEO sell | $620k 5,000 shares | -1% | - | |
| 44Moderate | John Farahi CEO sell | $604k 5,000 shares | -1% | +47% from low0% from high | |
| 39Weak | John Farahi CEO sell | $295k 3,000 shares | -1% | +37% from low-9% from high | |
| 45Moderate | John Farahi CEO sell | $619k 6,000 shares | -1% | +45% from low-3% from high | |
| 30Weak | John Farahi CEO sell | $212k 2,000 shares | -0% | +48% from low0% from high | |
| 68Notable | Craig F Sullivan director sell | $1.3M 12,200 shares | -100% | +48% from low0% from high | |
| 38Weak | John Farahi CEO sell | $231k 3,000 shares | -1% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 16, 2026 | FARAHI JOHN Officer, Director, 10% Stockholder | 5,000 0.03% of outstanding | $617k | Sep 16, 2026 | none |
| May 28, 2026 | FARAHI JOHN Officer, Director, 10% Stockholder | 5,000 0.03% of outstanding | $602k | May 28, 2026 | $293k |
| Mar 16, 2026 | FARAHI JOHN Officer | 2,000 0.01% of outstanding | $197k | Mar 16, 2026 | $197k |
| Mar 10, 2026 | FARAHI JOHN Officer | 1,000 0.01% of outstanding | $97k | Mar 10, 2026 | $100k |
| Feb 10, 2026 | Andrews Paul Officer | 6,100 0.03% of outstanding | $594k | Feb 9, 2026 | none |
| Jan 6, 2026 | Yvette Landau Director | 61,000 0.33% of outstanding | $5.7M | Jan 6, 2026 | none |
| Dec 16, 2025 | FARAHI JOHN Officer | 1,000 0.01% of outstanding | $100k | Dec 16, 2025 | $96k |
| Nov 21, 2025 | FARAHI JOHN Officer | 1,000 0.01% of outstanding | $96k | Nov 21, 2025 | $516k |
| Aug 26, 2025 | FARAHI JOHN Officer | 1,977 0.01% of outstanding | $204k | Aug 26, 2025 | $521k |
| Aug 25, 2025 | FARAHI JOHN Officer | 3,023 0.02% of outstanding | $312k | Aug 25, 2025 | $209k |
| Aug 22, 2025 | SULLIVAN CRAIG F Director | 5,376 0.03% of outstanding | $565k | Aug 22, 2025 | $77k |
| Jul 25, 2025 | SULLIVAN CRAIG F Director | 724 0.00% of outstanding | $77k | Jul 24, 2025 | none |
| Jul 22, 2025 | FARAHI JOHN Officer | 2,000 0.01% of outstanding | $209k | Jul 22, 2025 | none |
| Jul 22, 2025 | SULLIVAN CRAIG F Director | 12,200 0.07% of outstanding | $1.3M | Jul 22, 2025 | none |
| Jul 21, 2025 | Koenig Edwin S. Officer | 9,999 0.05% of outstanding | $1.0M | Jul 21, 2025 | none |
| May 2, 2025 | Yvette Landau Director | 6,100 0.03% of outstanding | $477k | May 2, 2025 | none |
| Mar 6, 2025 | Andrews Paul Director | 3,100 0.02% of outstanding | $271k | Mar 6, 2025 | none |
| Jan 3, 2025 | FARAHI JOHN Officer, Director, 10% Stockholder | 1,000 0.01% of outstanding | $77k | Jan 3, 2025 | $152k |
| Nov 29, 2024 | Koenig Edwin S. Officer | 3,334 0.02% of outstanding | $288k | Nov 29, 2024 | none |
| Nov 27, 2024 | SULLIVAN CRAIG F Officer | 6,100 0.01% of outstanding | $525k | Nov 26, 2024 | none |
| Oct 15, 2024 | FARAHI JOHN Officer, Director, 10% Stockholder | 2,000 0.01% of outstanding | $152k | Oct 15, 2024 | none |
Transactions
The newest 50 of 62 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | John Farahi CEO | SOpen-market sale Common Stock | -5,000 | $124.00 | $620k | 611,556 | 22 d ago |
| Jun 30, 2026 | Hope S Taitz director | AGrant or award Option/Right to Buyderivative | +6,100 | $131.61 | $803k | 6,100 | Jul 7, 2026 |
| Jun 30, 2026 | Edwin S. Koenig CAO | AGrant or award Option/Right to Buyderivative | +5,000 | $131.61 | $658k | 20,001 | Jul 6, 2026 |
| Jun 30, 2026 | Craig F Sullivan director | AGrant or award Option/Right to Buyderivative | +6,100 | $131.61 | $803k | 42,700 | Jul 6, 2026 |
| Jun 30, 2026 | Paul Andrews director | AGrant or award Options/Right to Buyderivative | +6,100 | $131.61 | $803k | 57,900 | Jul 2, 2026 |
| May 28, 2026 | John Farahi CEO | SOpen-market sale Common Stock | -5,000 | $120.84 | $604k | 616,556 | May 29, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Common Stock | +66,666 | $23.08 | $1.5M | 602,970 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Common Stock | +66,668 | $45.32 | $3.0M | 669,638 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Common Stock | +66,666 | $39.82 | $2.7M | 736,304 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | FTax withholding Common Stock | -114,748 | $118.16 | $14M | 621,556 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Options / Right to Buyderivative | -66,666 | $0.00 | $0 | 600,000 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Options / Right to Buyderivative | -66,668 | $0.00 | $0 | 533,332 | Apr 30, 2026 |
| Apr 28, 2026 | John Farahi CEO | MOption exercise Options / Right to Buyderivative | -66,666 | $0.00 | $0 | 466,666 | Apr 30, 2026 |
| Apr 23, 2026 | Bob Farahi President | MOption exercise Common Stock | +66,667 | $116.65 | $7.8M | 248,353 | Apr 24, 2026 |
| Apr 23, 2026 | Bob Farahi President | FTax withholding Common Stock | -51,175 | $116.65 | $6.0M | 197,178 | Apr 24, 2026 |
| Apr 23, 2026 | Bob Farahi President | MOption exercise Options / Right to Buyderivative | -33,334 | $0.00 | $0 | 133,333 | Apr 24, 2026 |
| Apr 23, 2026 | Bob Farahi President | MOption exercise Options / Right to Buyderivative | -33,333 | $0.00 | $0 | 100,000 | Apr 24, 2026 |
| Mar 10, 2026 | John Farahi CEO | SOpen-market sale Common Stock | -1,000 | $97.43 | $97k | 538,304 | Mar 25, 2026 |
| Mar 16, 2026 | John Farahi CEO | SOpen-market sale Common Stock | -2,000 | $99.00 | $198k | 536,304 | Mar 25, 2026 |
| Feb 9, 2026 | Paul Andrews director | SOpen-market sale Options / Right to Buyderivative | -3,000 | $97.40 | $292k | 54,900 | Feb 12, 2026 |
| Feb 9, 2026 | Paul Andrews director | SOpen-market sale Options / Right to Buyderivative | -3,100 | $97.40 | $302k | 51,800 | Feb 12, 2026 |
| Jan 13, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -2,684 | $92.12 | $247k | 46,116 | Jan 16, 2026 |
| Jan 14, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -3,416 | $91.10 | $311k | 42,700 | Jan 16, 2026 |
| Jan 14, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $91.10 | $556k | 36,600 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $91.85 | $560k | 30,500 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $91.85 | $560k | 24,400 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $92.24 | $563k | 18,300 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $92.24 | $563k | 12,200 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $92.24 | $563k | 6,100 | Jan 16, 2026 |
| Jan 15, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $92.24 | $563k | 0 | Jan 16, 2026 |
| Aug 26, 2025 | John Farahi CEO | SOpen-market sale Common Stock | -5,000 | $103.77 | $519k | 554,110 | Jan 9, 2026 |
| Jan 6, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -2,302 | $94.11 | $217k | 58,698 | Jan 9, 2026 |
| Dec 17, 2025 | John Farahi CEO | SOpen-market sale Common Stock | -1,000 | $100.63 | $101k | 553,110 | Jan 9, 2026 |
| Sep 29, 2025 | John Farahi CEO | GGift Common Stock | -13,806 | $104.60 | $1.4M | 539,304 | Jan 9, 2026 |
| Jan 8, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -3,798 | $94.13 | $357k | 54,900 | Jan 9, 2026 |
| Jan 8, 2026 | Yvette Landau director | SOpen-market sale Options / Right to Buyderivative | -6,100 | $94.13 | $574k | 48,800 | Jan 9, 2026 |
| Sep 29, 2025 | John Farahi CEO | GGift Common Stockindirect: In trusts | +13,806 | $104.60 | $1.4M | 2,521,415 | Jan 9, 2026 |
| Dec 31, 2025 | John Farahi CEO | AGrant or award Options / Right to Buyderivative | +66,666 | $95.70 | $6.4M | 666,666 | Jan 9, 2026 |
| Dec 31, 2025 | Bob Farahi President | AGrant or award Options / Right to Buyderivative | +33,333 | $95.70 | $3.2M | 166,667 | Jan 7, 2026 |
| Aug 22, 2025 | Craig F Sullivan director | SOpen-market sale Options / Right to Buyderivative | -5,376 | $105.00 | $564k | 42,700 | Aug 25, 2025 |
| Jul 24, 2025 | Craig F Sullivan director | SOpen-market sale Options / Right to Buyderivative | -724 | $106.98 | $77k | 48,076 | Jul 29, 2025 |
| Jul 22, 2025 | Craig F Sullivan director | SOpen-market sale Common Stock | -12,200 | $105.55 | $1.3M | 0 | Jul 23, 2025 |
| Jul 21, 2025 | John Farahi CEO | MOption exercise Common Stock | +66,666 | $17.62 | $1.2M | 595,102 | Jul 23, 2025 |
| Jul 21, 2025 | John Farahi CEO | FTax withholding Common Stock | -32,992 | $105.39 | $3.5M | 562,110 | Jul 23, 2025 |
| Jul 22, 2025 | John Farahi CEO | SOpen-market sale Common Stock | -2,000 | $105.78 | $212k | 560,110 | Jul 23, 2025 |
| Jul 21, 2025 | John Farahi CEO | AGrant or award Options / Right to Buyderivative | +66,666 | $0.00 | $0 | 600,000 | Jul 23, 2025 |
| Jul 21, 2025 | Edwin S. Koenig CAO | SOpen-market sale Options / Right to Buyderivative | -4,999 | $103.94 | $520k | 15,001 | Jul 22, 2025 |
| Jul 21, 2025 | Edwin S. Koenig CAO | SOpen-market sale Options / Right to Buyderivative | -1,667 | $103.94 | $173k | 15,001 | Jul 22, 2025 |
| Jul 21, 2025 | Edwin S. Koenig CAO | SOpen-market sale Options / Right to Buyderivative | -3,333 | $103.94 | $346k | 15,001 | Jul 22, 2025 |
| Jun 30, 2025 | Edwin S. Koenig CAO | AGrant or award Options / Right to Buyderivative | +5,000 | $86.44 | $432k | 25,000 | Jul 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Paul Andrewsdirector
- Bob FarahiPresident
- John FarahiCEO
- Edwin S. KoenigCAO
- Yvette Landaudirector
- Craig F Sullivandirector
- Hope S Taitzdirector
Questions about MCRI
Answered from the filings on this page, as of the latest one.
Are insiders buying MCRI?
As of Sep 21, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $620k by 1 insider at MONARCH CASINO & RESORT INC in the last 90 days, net -$620k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade MCRI on the open market?
John Farahi (CEO) sold $620k of MCRI on Sep 17, 2026 and filed the Form 4 on Sep 21, 2026. InsiderTell scored 45 (moderate).
How many insiders file Form 4 at MONARCH CASINO & RESORT INC?
7 people have filed a Form 4 at MONARCH CASINO & RESORT INC, among them Paul Andrews (director), Bob Farahi (President), John Farahi (CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.